International Clinical Trial: A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315360) titled 'A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function' on Dec. 18, 2025.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Renal Impairment Healthy

Intervention: Drug: PF-07328948

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: January 18, 2026

Target Sample Size: 28

To know more, visit https://clinicaltrials.gov/study/NCT07315360

Published by HT Digital Content Serv...